Skip to the page

Data / Form D filings / Halda Therapeutics, LLC

Halda Therapeutics, LLC: Form D filings

Halda Therapeutics, LLC, a health care company in New Haven, CT, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on August 12, 2024, reports $126.5 million sold of a $126.5 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
115 MUNSON STREET, SUITE 101, New Haven, CT, 06511
Phone
(860) 655-8653
Industry
Other Health Care
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1769401

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 12, 2024New notice$126,471,316$126,471,31620Jul 31, 2024sec.gov
May 24, 2024New notice$36,000,000$24,211,678$11,788,3229May 21, 2024sec.gov
Dec 10, 2021New notice$51,000,000$40,990,001$10,009,99911Dec 1, 2021sec.gov
Mar 1, 2019New notice$25,150,000$6,250,743$18,899,25712Feb 22, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Liam RatcliffeDirector
Nandita ShangariDirector
Tim ShannonExecutive Officer, Director
Joe CabralDirector
Rebecca FreyDirector
Rebecca LuseDirector
Arjun GoyalDirector
Scott PhillipsExecutive Officer

Other health care companies in Connecticut that filed recently

Every Form D from the week of Aug 12, 2024 · All recent filings in Connecticut · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Halda Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.